Results for tag: "Medicinal Fungi"

The Medicinal Fungi market is a subset of the Drug Discovery industry, focusing on the use of fungi for the development of new drugs. Fungi have been used for centuries in traditional medicine, and modern research has revealed a wealth of potential therapeutic compounds. Fungi are a rich source of bioactive compounds, including antibiotics, antivirals, immunomodulators, and anti-cancer agents. These compounds can be used to develop new drugs, as well as to improve existing treatments. The Medicinal Fungi market is driven by the increasing demand for new and improved treatments for a variety of diseases. The market is also driven by advances in technology, which have enabled researchers to identify and isolate new compounds from fungi. Companies in the Medicinal Fungi market include Novozyme, Gilead Sciences, AstraZeneca, and Merck. These companies are involved in the research and development of new drugs derived from fungi, as well as the production and marketing of existing drugs. Show Less Read more